Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -165.57% is 19% above its 5-year average of -203.25%, near the high end of its 5-year range (-812.29%–-128.42%).
As of the fiscal period ended Tuesday, June 30, 2026. 8.95% below its 12-month average of -151.97%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -165.57%.
RETURN ON EQUITY (ROE)
-165.57%
RETURN ON EQUITY (ROE) AVG TTM
-151.97%
RETURN ON EQUITY (ROE) AVG 3Y
-245.11%
RETURN ON EQUITY (ROE) AVG 5Y
-203.25%
RETURN ON EQUITY (ROE) AVG 10Y
N/A
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-8.95%
CURRENT VS 3Y AVG
+32.45%
CURRENT VS 5Y AVG
+18.54%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-41.10%
median of 719 covered companies
CURRENT VS SECTOR MEDIAN
-302.86%
vs the sector median at left
TuHURA Biosciences, Inc.
Market Cap
$122.27M
Return on Equity (ROE)
-165.57%
TTM Avg
-151.97%
3Y Avg
-245.11%
5Y Avg
-203.25%
Market Cap
$123.07M
Return on Equity (ROE)
-5.10%
TTM Avg
-4.24%
3Y Avg
-6.16%
5Y Avg
0.09%
Market Cap
$121.05M
Return on Equity (ROE)
-30.12%
TTM Avg
-27.41%
3Y Avg
-24.34%
5Y Avg
-19.85%
Market Cap
$120.90M
Return on Equity (ROE)
-2.13%
TTM Avg
-45.09%
3Y Avg
-61.80%
5Y Avg
-44.27%
Market Cap
$120.60M
Return on Equity (ROE)
-663.38%
TTM Avg
-427.48%
3Y Avg
-294.92%
5Y Avg
-251.31%
Market Cap
$119.81M
Return on Equity (ROE)
-148.56%
TTM Avg
-96.59%
3Y Avg
-83.25%
5Y Avg
-64.44%
Market Cap
$119.50M
Return on Equity (ROE)
-61.33%
TTM Avg
-137.84%
3Y Avg
-101.43%
5Y Avg
-77.25%
Market Cap
$125.37M
Return on Equity (ROE)
-71.83%
TTM Avg
-71.89%
3Y Avg
-76.88%
5Y Avg
-67.88%
Market Cap
$126.64M
Return on Equity (ROE)
N/A
TTM Avg
143.89%
3Y Avg
2.05%
5Y Avg
-53.47%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| TuHURA Biosciences, Inc. (HURA) | $122.27M | -165.57% | -151.97% | -245.11% | -203.25% |
| BGM Group Ltd. (BGM)vs › | $123.07M | -5.10% | -4.24% | -6.16% | 0.09% |
| Seer, Inc. (SEER)vs › | $121.05M | -30.12% | -27.41% | -24.34% | -19.85% |
| enGene Holdings Inc. (ENGN)vs › | $120.90M | -2.13% | -45.09% | -61.80% | -44.27% |
| Cibus, Inc. (CBUS)vs › | $120.60M | -663.38% | -427.48% | -294.92% | -251.31% |
| Tenaya Therapeutics, Inc. (TNYA)vs › | $119.81M | -148.56% | -96.59% | -83.25% | -64.44% |
| Spruce Biosciences, Inc. (SPRB)vs › | $119.50M | -61.33% | -137.84% | -101.43% | -77.25% |
| Tonix Pharmaceuticals Holding Corp. (TNXP)vs › | $125.37M | -71.83% | -71.89% | -76.88% | -67.88% |
| NRx Pharmaceuticals, Inc. (NRXP)vs › | $126.64M | N/A | 143.89% | 2.05% | -53.47% |
| Entera Bio Ltd. (ENTX)vs › | $126.92M | -234.42% | -102.69% | -100.55% | -100.92% |
ROE
-165.6%
ROA
-96.5%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -165.57% |
| 2026-03-31 | -133.39% |
| 2025-12-31 | -143.61% |
| 2025-09-30 | -174.55% |
| 2025-06-30 | -142.74% |
| 2025-03-31 | -208.63% |
| 2024-12-31 | -128.42% |
| 2024-09-30 | -812.29% |
| 2024-06-30 | -296.81% |
| 2023-03-31 | -233.93% |
| 2022-12-31 | -285.72% |
| 2022-09-30 | -221.37% |
| 2022-06-30 | -192.12% |
| 2022-03-31 | -255.14% |
| 2021-12-31 | -178.88% |
| 2021-09-30 | -129.13% |
| 2021-06-30 | -361.95% |
| 2021-03-31 | -219.56% |
| 2020-12-31 | -174.64% |
| 2020-09-30 | -131.55% |
| 2020-03-31 | -211.95% |
| 2019-12-31 | -138.54% |
| 2019-09-30 | -109.07% |
| 2019-06-30 | -409.05% |
| 2019-03-31 | -622.85% |
| 2018-12-31 | -463.11% |
| 2018-09-30 | -285.07% |
| 2018-06-30 | -204.93% |
| 2018-03-31 | -148.33% |
| 2017-12-31 | -189.46% |
| 2017-09-30 | -65.47% |
| 2017-06-30 | -122.85% |
